Ping Cai from Newington, CT, age 39

view source

Specialties:

Dentistry

Address:

40 Village Ct, Hazlet, NJ 07730
7322648001 (Phone)

Languages:

English
Chinese

view source

Specialties:

Dentist

Address:

40 Village Ct, Hazlet, NJ 07730

view source

view source

view source

view source

Address:

Morrison & Foerster LLP
1059093311 (Office)

Licenses:

New York - Delinquent 2007

Education:

Boston University School of Law

view source

ISLN:

923929426

Admitted:

2007

Law School:

Boston University School of Law, J.D., 2007

Cci-779 Derivatives And Methods Of Making Same
view source
US Patent:

7332601, Feb 19, 2008
Filed:

Aug 9, 2005
Appl. No.:

11/200383
Inventors:

Ping Cai - New City NY, US
Mark Ruppen - Garnerville NY, US
Russ Tsao - Tenafly NJ, US
Assignee:

Wyeth - Madison NJ
International Classification:

C07D 498/22
US Classification:

540456
Abstract:

A method of generating synthetic metabolites of CCI-779 is provided. Five novel CCI-779 derivatives are described, as are methods of using these derivatives for detecting CCI-779 metabolites in samples.

Process For Preparing Rapamycin 42-Esters And Fk-506 32-Esters With Dicarboxylic Acid, Precursors For Rapamycin Conjugates And Antibodies
view source
US Patent:

7445916, Nov 4, 2008
Filed:

Apr 12, 2005
Appl. No.:

11/104349
Inventors:

Jianxin Gu - River Edge NJ, US
Ping Cai - New City NY, US
Mark E. Ruppen - Garnerville NY, US
Assignee:

Wyeth - Madison NJ
International Classification:

C12P 17/16
C12P 17/18
US Classification:

435118, 435119
Abstract:

Methods for the synthesis of regiospecific rapamycin 42-hemiesters and regiospecific FK506 32-esters with dicarboxylic acids is described. The methods involve catalyzing the reaction between a rapamycin or a FK-506 and a dicarboxylic anhydride or a bifunctional activated ester of dicarboxylic acid with a lipase.

Process For Preparing Rapamycin 42-Esters And Fk-506 32-Esters With Dicarboxylic Acid, Precursors For Rapamycin Conjugates And Antibodies
view source
US Patent:

7625726, Dec 1, 2009
Filed:

Sep 29, 2008
Appl. No.:

12/240230
Inventors:

Jianxin Gu - River Edge NJ, US
Ping Cai - New City NY, US
Mark E. Ruppen - Garnerville NY, US
Assignee:

Wyeth - Madison NJ
International Classification:

C12P 17/16
C12P 17/18
US Classification:

435118, 435119
Abstract:

Methods for the synthesis of regiospecific rapamycin 42-hemiesters and regiospecific FK506 32-esters with dicarboxylic acids is described. The methods involve catalyzing the reaction between a rapamycin or a FK-506 and a dicarboxylic anhydride or a bifunctional activated ester of dicarboxylic acid with a lipase.

Regiospecific Synthesis Of Rapamycin 42-Ester Derivatives
view source
US Patent:

7268144, Sep 11, 2007
Filed:

Apr 12, 2005
Appl. No.:

11/103799
Inventors:

Jianxin Gu - River Edge NJ, US
Ping Cai - New City NY, US
Mark E. Ruppen - Garnerville NY, US
Assignee:

Wyeth - Madison NJ
International Classification:

C07D 498/18
A61K 31/395
US Classification:

514291, 540456
Abstract:

A method for the regiospecific synthesis of rapamycin 42-ester derivatives is described. The method involves lipase-catalyzed acetylation of 42-hydroxy of rapamycin with an acyl donor such as a vinyl ester, an isopropenyl ester or an anhydride in a suitable organic solvent.

Antifungal Antibiotics
view source
US Patent:

20040138302, Jul 15, 2004
Filed:

Dec 18, 2003
Appl. No.:

10/740042
Inventors:

Ping Cai - New City NY, US
Fangming Kong - River Vale NJ, US
Pamela Charbonneau - New City NY, US
Mark Ruppen - Garnerville NY, US
Assignee:

Wyeth Holdings Corporation - Madison NJ
International Classification:

C11D001/28
A61K031/255
A61K031/225
US Classification:

514/547000, 514/550000, 514/558000, 514/517000, 554/090000
Abstract:

This disclosure describes antifungal antibiotics designated Hygroscopene A, Hygroscopene B and Hygroscopene C to their production by fermentation, to methods for recovery and concentration from the crude solutions, to a process for purification and to new analogs of Hygroscopene A, Hygroscopene B and Hygroscopene C prepared by synthetic procedures.

Pharmaceutical Dosage Forms And Compositions
view source
US Patent:

20050215561, Sep 29, 2005
Filed:

Mar 17, 2005
Appl. No.:

11/082548
Inventors:

Krishnendu Ghosh - Sparkill NY, US
Arwinder Nagi - Thiells NY, US
Xiaohong Pan - Highland Mills NY, US
Melissa Lin - Wanaque NY, US
Leonid Linberg - Upper Saddle River NJ, US
Ping Cai - New City NY, US
Eric Browne - Pierrefonds, CA
Michel Bernatchez - Montreal, CA
Mark Lankau - Dollard des Ormeaux, CA
International Classification:

A61K031/496
C07D045/14
US Classification:

514252110, 544357000
Abstract:

This invention relates to, for example, novel formulations and methods for the delivery of 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5yl)-piperazin-1-yl]-propyl}-N-pyridin-2-yl-benzamide, pharmaceutically acceptable salts thereof, structurally related compounds and/or metabolites; as well as to use of these formulations and methods for treating disease.

Pharmaceutical Dosage Forms And Compositions
view source
US Patent:

20070099931, May 3, 2007
Filed:

Sep 6, 2006
Appl. No.:

11/517605
Inventors:

Krishnendu Ghosh - Sparkill NY, US
Arwinder Nagi - Thiells NY, US
Xiaohong Pan - Highland Mills NY, US
Melissa Lin - Wanaque NJ, US
Leonid Linberg - Upper Saddle River NJ, US
Ping Cai - New City NY, US
Eric Browne - Quebec, CA
Michel Bernatchez - Montreal, CA
Mark Lankau - Dollard des Ormeaux, CA
Sangeeta Raje - Audubon PA, US
Assignee:

Wyeth - Madison NJ
International Classification:

A61K 31/496
US Classification:

514253110
Abstract:

The invention relates to, for example, novel formulations and methods for the delivery of 4-cyano-N-{(2R)—2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-N-pyridin-2-yl-benzamide, pharmaceutically acceptable salts thereof, structurally related compounds and/or metabolites; as well as to use of these formulations and methods for treating disease.